Lupin share price has plunged 3% and is presently trading at Rs 2,109.4.
Meanwhile, the BSE HEALTHCARE index is at 43,468.1 (down 0.9%).
Among the top losers in the BSE HEALTHCARE index today are FORTIS HEALTHCARE (down 3.6%) and Aurobindo Pharma (down 3.3%).
GLAND PHARMA (up 11.9%) and Procter & Gamble Health (up 6.9%) are among the top gainers today.
Over the last one year, Lupin has moved up from Rs 1,132.6 to Rs 2,109.4, registering a gain of Rs 976.8 (up 86.2%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,350.0 to 43,468.1, registering a gain of 58.9% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 228.0%), SUVEN PHARMACEUTICALS (up 132.5%) and Glenmark Pharma (up 123.8%).
Don't Miss: Key Information for Long-term Investors
The BSE Sensex is at 78,423.7 (down 0.5%).
The top losers among the BSE Sensex today are MUNDRA PORT & SEZ (down 3.2%) and Bajaj Finance (down 1.6%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 23,889.1 (down 0.4%). HDFC LIFE INSURANCE and MUNDRA PORT & SEZ are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 63,591.3 to 78,423.7, registering a gain of 14,832.4 points (up 23.3%).
Lupin net profit grew 77.7% YoY to Rs 8,055 million for the quarter ended June 2024, compared to a profit of Rs 4,533 million a year ago. Net sales rose 16.3% to Rs 56,003 million during the period as against Rs 48,141 million in April-June 2023.
For the year ended March 2024, Lupin reported 332.3% increase in net profit to Rs 19,356 million compared to net profit of Rs 4,477 million during FY23. Revenue of the company grew 20.2% to Rs 200,108 million during FY24.
The current Price to earnings ratio of Lupin, based on rolling 12 month earnings, stands at 42.1.
Equitymaster requests your view! Post a comment on "Lupin Plunges 3%; BSE HEALTHCARE Index Down 0.9%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!